NO2822887T3 - - Google Patents
Info
- Publication number
- NO2822887T3 NO2822887T3 NO13757678A NO13757678A NO2822887T3 NO 2822887 T3 NO2822887 T3 NO 2822887T3 NO 13757678 A NO13757678 A NO 13757678A NO 13757678 A NO13757678 A NO 13757678A NO 2822887 T3 NO2822887 T3 NO 2822887T3
- Authority
- NO
- Norway
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13/284,739 US20120107825A1 (en) | 2010-11-01 | 2011-10-28 | Methods and compositions for assessing patients with reproductive failure using immune cell-derived microrna |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO2822887T3 true NO2822887T3 (no) | 2017-12-30 |
Family
ID=45997174
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO13757678A NO2822887T3 (no) | 2011-10-28 | 2013-02-28 |
Country Status (8)
| Country | Link |
|---|---|
| US (4) | US20120107825A1 (no) |
| EP (1) | EP2771490B1 (no) |
| CN (2) | CN104039983B (no) |
| AU (1) | AU2012328689A1 (no) |
| CA (1) | CA2853377C (no) |
| ES (1) | ES2666282T3 (no) |
| NO (1) | NO2822887T3 (no) |
| WO (1) | WO2013063322A1 (no) |
Families Citing this family (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013179672A1 (ja) * | 2012-05-31 | 2013-12-05 | 武田薬品工業株式会社 | 子宮内膜症の判定方法 |
| WO2014004677A1 (en) * | 2012-06-27 | 2014-01-03 | Memorial Sloan-Kettering Cancer Center | Method of reducing the risk of pregnancy complications |
| CN103667281A (zh) * | 2012-08-30 | 2014-03-26 | 苏州博泰安生物科技有限公司 | 前列腺癌分子标志物miR-301a及其应用 |
| US9177098B2 (en) | 2012-10-17 | 2015-11-03 | Celmatix Inc. | Systems and methods for determining the probability of a pregnancy at a selected point in time |
| CN103571843A (zh) * | 2013-10-11 | 2014-02-12 | 安徽瀚海博兴生物技术有限公司 | 一种抑制胚胎着床的包裹有微小rna的纳米颗粒 |
| KR101535737B1 (ko) * | 2014-01-09 | 2015-07-09 | 충남대학교산학협력단 | miRNA를 포함하는 자간전증 진단 및 치료용 조성물 |
| AU2015229270B2 (en) | 2014-03-12 | 2020-12-24 | Icahn School Of Medicine At Mount Sinai | Method for identifying kidney allograft recipients at risk for chronic injury |
| US20170097358A1 (en) * | 2014-03-21 | 2017-04-06 | Igenomix S.L. | Early detection of preeclampsia |
| CN103920164B (zh) * | 2014-05-05 | 2015-09-02 | 山东大学 | MiR-424-5p在抑制转移性肝癌中的应用 |
| AU2015279542B2 (en) | 2014-06-26 | 2021-07-29 | Icahn School Of Medicine At Mount Sinai | Method for diagnosing subclinical and clinical acute rejection by analysis of predictive gene sets |
| US10308985B2 (en) | 2014-06-26 | 2019-06-04 | Icahn School Of Medicine At Mount Sinai | Methods for diagnosing risk of renal allograft fibrosis and rejection |
| GB201503792D0 (en) | 2015-03-06 | 2015-04-22 | Imp Innovations Ltd | Method |
| GB201504772D0 (en) * | 2015-03-20 | 2015-05-06 | Univ Aston | Preeclampsia |
| US10358676B2 (en) * | 2015-04-03 | 2019-07-23 | Kaohsiung Chang Gung Memorial Hospital | Methods and kits for detecting Kawasaki disease |
| WO2017180984A1 (en) * | 2016-04-14 | 2017-10-19 | The Texas A&M University System | First trimester epigenetic and microrna biomarkers for preeclampsia |
| WO2017182580A1 (en) * | 2016-04-20 | 2017-10-26 | Inserm (Institut National De La Sante Et De La Recherche Medicale) | Methods for the diagnosis and the treatment of reproduction-related disorders and methods for contraception |
| US11643690B2 (en) * | 2016-11-02 | 2023-05-09 | Mirdetect Gmbh | Early detection of preliminary stages of testicular germ cell tumors |
| WO2018167790A1 (en) | 2017-03-16 | 2018-09-20 | Ramot At Tel-Aviv University Ltd. | Methods for identifying and monitoring pregnant women at risk of preeclampsia |
| WO2018187585A1 (en) * | 2017-04-06 | 2018-10-11 | Celmatix Inc. | Methods for assessing the potential for reproductive success and informing treatment therefrom |
| CN109022565B (zh) * | 2017-06-12 | 2022-02-11 | 山大生殖研发中心有限公司 | 多囊卵巢综合征的microRNA生物标记物和其应用 |
| CN107400728A (zh) * | 2017-09-21 | 2017-11-28 | 西安医学院 | miR‑155作为分子标记物在诊断子痫前期中的应用 |
| CN107519194B (zh) | 2017-10-09 | 2018-05-18 | 南京鼓楼医院 | miR-21在制备治疗宫腔粘连和/或薄型内膜的药物中的应用 |
| IL275273B1 (en) * | 2017-12-15 | 2024-05-01 | Medizinische Hochschule Hannover | An improved compound for the treatment of heart failure |
| CN108992457A (zh) * | 2018-01-15 | 2018-12-14 | 广东省实验动物监测所 | miR-144-3p及其靶基因在制备调节人心脏成纤维细胞功能的药物中的应用 |
| JP7464279B2 (ja) | 2018-04-16 | 2024-04-09 | アイカーン スクール オブ メディスン アット マウント シナイ | レシピエント血液における移植前トランスクリプトームシグネチャーを使用した急性拒絶反応および腎臓同種異系移植喪失の予測のための方法およびキット |
| CN110872621A (zh) * | 2018-08-29 | 2020-03-10 | 宣捷干细胞生技股份有限公司 | 用于判定怀孕女性个体的子痫前期发生风险的试剂或试剂盒 |
| CN111041082B (zh) * | 2018-10-11 | 2023-11-07 | 伽蓝（集团）股份有限公司 | 一种以皮肤光老化靶标筛选改善皮肤光老化的活性物的方法及改善皮肤光老化的活性物 |
| CN109971851A (zh) * | 2019-01-22 | 2019-07-05 | 宁波大学 | MiR-125b-2-3p作为鉴别诊断肾癌亚型的分子标志物及其在肿瘤转移中的用途 |
| EP3935190A4 (en) * | 2019-03-08 | 2023-03-29 | Edward E. Winger, M.D., Professional Corporation | REAGENTS, METHODS AND KITS FOR IDENTIFYING PREGNANT PEOPLE AT RISK OF PLACENTAL DISEASE |
| CN110804659B (zh) * | 2019-10-23 | 2023-02-03 | 华南农业大学 | 一种血清外泌体ssc-miR-92b-3p作为母猪早期妊娠诊断分子标志物的应用 |
| CN110938687B (zh) * | 2019-12-26 | 2023-06-27 | 广州医科大学附属第三医院（广州重症孕产妇救治中心、广州柔济医院） | 胎盘植入性疾病标志物 |
| WO2021231475A2 (en) * | 2020-05-11 | 2021-11-18 | Brooklyn Innoseq Inc. | Systems and methods of promoting eubiosis in pregnant or breastfeeding women |
| US20230332234A1 (en) * | 2020-09-23 | 2023-10-19 | Ewinger, Inc. | Reagents, methods and kits for identifying pregnant human beings at risk for placental bed disorder(s) |
| KR102366856B1 (ko) | 2021-04-23 | 2022-02-23 | 이화여자대학교 산학협력단 | 레티노이드 대사체를 이용한 조산의 조기 예측 방법 |
| CN113736877A (zh) * | 2021-10-15 | 2021-12-03 | 青岛大学附属医院 | 基于微小RNA 27a的子痫前期诊断用途及组合物 |
| CN114010523B (zh) * | 2021-11-05 | 2024-04-12 | 天津穗纳生物医药科技有限公司 | 皮肤抗衰剂及其应用 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040105858A1 (en) | 2002-08-29 | 2004-06-03 | Kim Joanne Young Hee Kwak | Diagnosis and treatment of infertility |
| US20080009552A1 (en) * | 2006-03-23 | 2008-01-10 | Craig Pennell | Markers of pre-term labor |
| EP2613149B1 (en) * | 2007-07-25 | 2014-09-17 | University Of Louisville Research Foundation, Inc. | Exosome-associated microRNA as a diagnostic marker |
| US20090123933A1 (en) | 2007-11-12 | 2009-05-14 | Wake Forest University Health Sciences | Microrna biomarkers in lupus |
| US7964354B2 (en) * | 2007-12-20 | 2011-06-21 | Celgene Corporation | Use of micro-RNA as a biomarker of immunomodulatory drug activity |
| CA2708661A1 (en) * | 2008-01-27 | 2009-07-30 | Rosetta Genomics Ltd. | Methods and compositions for diagnosing complications of pregnancy |
| WO2009134452A2 (en) | 2008-05-01 | 2009-11-05 | Swedish Health Services | Preterm delivery diagnostic assay |
| EP2336353A1 (en) * | 2009-12-17 | 2011-06-22 | febit holding GmbH | miRNA fingerprints in the diagnosis of diseases |
| EP2354246A1 (en) * | 2010-02-05 | 2011-08-10 | febit holding GmbH | miRNA in the diagnosis of ovarian cancer |
| EP3935190A4 (en) | 2019-03-08 | 2023-03-29 | Edward E. Winger, M.D., Professional Corporation | REAGENTS, METHODS AND KITS FOR IDENTIFYING PREGNANT PEOPLE AT RISK OF PLACENTAL DISEASE |
| US20230332234A1 (en) | 2020-09-23 | 2023-10-19 | Ewinger, Inc. | Reagents, methods and kits for identifying pregnant human beings at risk for placental bed disorder(s) |
-
2011
- 2011-10-28 US US13/284,739 patent/US20120107825A1/en not_active Abandoned
-
2012
- 2012-10-25 AU AU2012328689A patent/AU2012328689A1/en not_active Abandoned
- 2012-10-25 CN CN201280065238.1A patent/CN104039983B/zh active Active
- 2012-10-25 CN CN201910006113.5A patent/CN109666728B/zh active Active
- 2012-10-25 ES ES12844262.1T patent/ES2666282T3/es active Active
- 2012-10-25 EP EP12844262.1A patent/EP2771490B1/en active Active
- 2012-10-25 WO PCT/US2012/061994 patent/WO2013063322A1/en active Application Filing
- 2012-10-25 CA CA2853377A patent/CA2853377C/en active Active
-
2013
- 2013-02-28 NO NO13757678A patent/NO2822887T3/no unknown
- 2013-05-21 US US13/899,555 patent/US10323282B2/en active Active
-
2019
- 2019-02-13 US US16/274,672 patent/US11268147B2/en active Active
-
2022
- 2022-02-04 US US17/592,818 patent/US12012635B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CN109666728A (zh) | 2019-04-23 |
| US12012635B2 (en) | 2024-06-18 |
| US20220325345A1 (en) | 2022-10-13 |
| CA2853377C (en) | 2023-05-09 |
| EP2771490A1 (en) | 2014-09-03 |
| ES2666282T3 (es) | 2018-05-03 |
| CN104039983A (zh) | 2014-09-10 |
| WO2013063322A1 (en) | 2013-05-02 |
| CN104039983B (zh) | 2019-01-29 |
| CN109666728B (zh) | 2022-07-26 |
| EP2771490B1 (en) | 2018-01-17 |
| US20120107825A1 (en) | 2012-05-03 |
| US10323282B2 (en) | 2019-06-18 |
| US11268147B2 (en) | 2022-03-08 |
| US20130245135A1 (en) | 2013-09-19 |
| US20160333406A9 (en) | 2016-11-17 |
| EP2771490A4 (en) | 2015-08-19 |
| AU2012328689A1 (en) | 2014-05-08 |
| US20190249254A1 (en) | 2019-08-15 |
| CA2853377A1 (en) | 2013-05-02 |